ClinConnect ClinConnect Logo
Search / Trial NCT05738278

Heart Rate Informed Changes in Care for Non-Communicating Patients

Launched by UNIVERSITY OF OSLO · Feb 10, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Heart Rate Autistic Disorder Intellectual Disability Social Interaction Caregivers Developmental Disabilities Communication Biomarkers Pain

ClinConnect Summary

This clinical trial is focused on improving the care of patients who have autism spectrum disorder and communication difficulties, particularly those who cannot speak. The main goal is to find ways to reduce pain in these patients by using their heart rate as a signal. The researchers will look at how heart rate can help identify care procedures that might be uncomfortable for these patients and explore whether making changes based on heart rate can lead to less pain. Additionally, they want to see if communicating through heart rate over six weeks can improve the relationship between the patient and their caregiver.

To participate in this trial, individuals must be between 5 and 70 years old, diagnosed with autism spectrum disorder, and have difficulty communicating. They should also be living in a care home or attending a special school with staff available at least five days a week. Participants will need permission from their legal representative to join. This study is currently looking for volunteers and aims to create a better understanding of how to provide compassionate care to those who are nonverbal.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between 5 and 70 years of age at the time of data collection
  • Autism spectrum disorder as evaluated by clinical psychologist
  • Communication difficulties
  • Living at a care home with round-the-clock staff for at least five days a week; or attending one-to-one staffed school/day-care at least five days a week.
  • Written informed consent is obtained from the subjects' legal representative.
  • Exclusion Criteria:
  • - Having any autoimmune disorder or any type of cancer with ongoing chemotherapy.

About University Of Oslo

The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.

Locations

Oslo, , Norway

Oslo, , Norway

Oslo, , Norway

Patients applied

0 patients applied

Trial Officials

Bjørnar Hassel

Principal Investigator

University of Oslo

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials